Table 1 Expression of miR-1254 and Smurf1 in human gastric cancer according to patients’ clinicopathological characteristics

From: miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer

Characteristics

Number

miR-1254 expression

p-value

Smurf1 expression

p-value

High group

Low group

High group

Low group

Age (years)

 <60

29

13

16

0.595

14

15

0.507

 ≥60

61

31

30

 

34

27

 

Gender

 Male

42

23

19

0.297

23

19

0.799

 Female

48

21

27

 

25

23

 

Size (cm)

 <3

40

26

14

0.006*

15

25

0.007*

 ≥3

50

18

32

 

33

17

 

Histological type

 Well-moderately

35

23

12

0.011*

13

22

0.014*

 Poorly signet

55

21

34

 

35

20

 

Stage

 I/II

41

23

18

0.211

18

23

0.101

 III/IV

49

21

28

 

30

19

 

T grade

 T1+T2

34

20

14

0.142

16

18

0.353

 T3+T4

56

24

32

 

32

24

 

Lymph node metastasis

 Absent (N0)

37

25

12

0.003*

14

23

0.014*

 Present (N1–N3)

53

19

34

 

34

19

 
  1. Clinicopathological results were compared using Pearson χ2 tests
  2. *p < 0.05 statistically significant difference